MRNA
CFO
2022-09-06–present
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
James Mock is recorded as CFO at Moderna, Inc. (MRNA). Moderna, Inc. reported in an 8-K filed August 17, 2022 that James Mock was appointed Chief Financial Officer, effective September 6, 2022. The proxy statement of Moderna, Inc. reports total compensation of $5,857,761 for James Mock in fiscal 2025, including a base salary of $852,192. Disclosed compensation is on record for 4 fiscal years. James Mock has spoken on 2 earnings calls across 1 company, most recently for Moderna, Inc. on July 31, 2026.
“On August 17, 2022, Moderna, Inc. (the “Company”) announced that James Mock has been appointed to serve as the Company’s Chief Financial Officer (“CFO”), beginning September 6, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2022-09-06–present
Recorded roles and call appearances connecting this person to public companies.
MRNA
CFO
2022-09-06–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Moderna, Inc. (MRNA) | Chief Financial Officer | $852,192 | $5,857,761 |
| 2024 | Moderna, Inc. (MRNA) | Chief Financial Officer | $826,200 | $17,212,582 |
| 2023 | Moderna, Inc. (MRNA) | Chief Financial Officer | $792,308 | $4,317,185 |
| 2022 | Moderna, Inc. (MRNA) | Chief Financial Officer | $227,885 | $7,331,196 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.